Delivery Order SPE2DB20D3101-SPE2DB25FRUA6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,582.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is set to be completed by August 26, 2025, just one day after the award date of August 25, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23,885.70 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $180,469.23 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,154.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,524.09 delivery order on July 29, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed-price, competitively awarded contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,574.68 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The delivery order, which is not set-aside and carries firm fixed pricing, was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The product will be performed and delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $3,024.00 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order valued at $34,728.79 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used primarily for chronic obstructive pulmonary disease management. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, was awarded on August 20, 2025, through competitive procedures with no set-aside designation. The contract is being performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for pharmaceutical supplies valued at $2,186.63. The order is for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle and reflects the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUA6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,148.24 to AmerisourceBergen Drug Corp on August 29, 2025, for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle through December 2026 that enables the contractor to supply medications and medical supplies to military healthcare systems globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for the Defense Health Agency and military healthcare systems. The company holds extensive federal contract awards with the DLA Medical Supply Chain for a diverse portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The SPE2DX IDC under which this delivery order was issued represents one of the agency's primary vehicles for pharmaceutical procurement and demonstrates the contractor's capability to meet large-scale federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 8/29/25 |